GO:0046963 3'-phosphoadenosine 5'-phosphosulfate transport: Sulfation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046963 describes the directed movement of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), the universal sulfate donor, into, out of, or within cells via specific transporters.
• PAPS transport is mediated by PAPST1 (SLC35B2) and PAPST2 (SLC35B3), which deliver PAPS from the cytosol into the Golgi lumen for sulfation reactions.
• PAPS transporters are essential for glycosaminoglycan (GAG) sulfation, protein tyrosine sulfation, and other sulfotransferase-dependent processes.
• Dysregulation of PAPS transport is linked to colorectal carcinoma progression and embryonic stem cell differentiation defects.
• PAPS transport activity can be measured using radioactive or fluorescent PAPS analogs in vesicle-based assays.
• CRISPR-based knockout, knock-in, and overexpression models of SLC35B2/SLC35B3 enable causal dissection of PAPS transport in development and disease.
Description
3'-phosphoadenosine 5'-phosphosulfate (PAPS) is the universal sulfate donor for all sulfotransferase reactions in eukaryotes, and its transport across cellular membranes is a prerequisite for sulfation of glycans, proteins, and small molecules. The Gene Ontology term GO:0046963, 3'-phosphoadenosine 5'-phosphosulfate transport, captures the directed movement of PAPS into, out of, or within a cell, or between cells, by means of a transporter or pore. This process is distinct from PAPS synthesis, which occurs in the cytosol via the bifunctional enzyme PAPS synthetase. Understanding PAPS transport is critical because sulfation reactions occur predominantly in the Golgi lumen, yet PAPS is synthesized in the cytosol; thus, specific transporters are required to bridge this topological gap. The first molecular identification of a PAPS transporter was achieved by Kamiyama et al. (2003), who cloned and characterized a human PAPS transporter (PAPST1) that localizes to the Golgi membrane and is essential for glycosaminoglycan sulfation. Subsequent studies identified a second transporter, PAPST2, and demonstrated that both contribute to the maintenance and differentiation of mouse embryonic stem cells. More recently, PAPS transporters have been implicated in human colorectal carcinoma, where their expression levels correlate with tumor progression and sulfation capacity. These findings underscore the importance of GO:0046963 in development, tissue homeostasis, and cancer biology. From a methodological standpoint, PAPS transport activity can be assayed using radioactive PAPS or fluorescent derivatives in reconstituted vesicle systems, as well as by real-time RT-PCR and immunohistochemistry to monitor transporter expression. Such approaches are essential for linking genotype to phenotype in studies of sulfation-related diseases. This article provides a comprehensive overview of GO:0046963, covering its definition, molecular players, regulatory mechanisms, disease associations, and state-of-the-art research methods including CRISPR-based models.
3'-phosphoadenosine 5'-phosphosulfate transport At A Glance
| GO ID | GO:0046963 |
|---|---|
| GO term | 3'-phosphoadenosine 5'-phosphosulfate transport |
| Ontology | biological_process |
| Synonym | PAPS transport; adenosine 3'-phosphate 5'-phosphosulfate transport; 3'-phosphoadenosine 5'-phosphosulphate transport |
| Major function | Translocation of PAPS across cellular membranes to support sulfation reactions |
| Key transporters | PAPST1 (SLC35B2), PAPST2 (SLC35B3) |
| Subcellular location | Golgi membrane; also implicated in other organelles |
| Related process | Glycosaminoglycan biosynthesis, protein sulfation, xenobiotic metabolism |
What Is GO:0046963?
GO:0046963, 3'-phosphoadenosine 5'-phosphosulfate transport, is defined as the directed movement of 3'-phosphoadenosine 5'-phosphosulfate (PAPS), a naturally occurring mixed anhydride synthesized from adenosine 5'-phosphosulfate, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. In simpler terms, it is the process by which cells move PAPS, the primary sulfate donor, across membranes to the sites where sulfation occurs, primarily the Golgi lumen.
Why Is 3'-phosphoadenosine 5'-phosphosulfate transport Important in Cell Biology?
PAPS transport is a rate-limiting step for all sulfation reactions in the secretory pathway, and its disruption leads to profound defects in glycosaminoglycan biosynthesis, protein function, and cellular differentiation. Because sulfation modulates the activity of numerous signaling molecules, growth factors, and extracellular matrix components, PAPS transporters are emerging as critical regulators of development and disease, including cancer.
• Enables glycosaminoglycan (GAG) sulfation, which is essential for cartilage, skin, and connective tissue integrity.
• Supports protein tyrosine sulfation, a post-translational modification that regulates chemokine and adhesion receptor function.
• Required for embryonic stem cell maintenance and differentiation, as shown by PAPST1/2 knockout studies.
• Modulates xenobiotic metabolism by supplying PAPS to cytosolic sulfotransferases.
• Implicated in colorectal carcinoma progression, where PAPS transporter expression is altered.
• Provides a target for pharmacological modulation of sulfation in inflammatory and fibrotic diseases.
• Essential for normal brain development, as PAPS synthetase and transporters are highly expressed in neural tissues.
• Serves as a model for studying membrane transport of charged nucleotides and cofactors.
What Happens During 3'-phosphoadenosine 5'-phosphosulfate transport?
PAPS Synthesis and Cytosolic Availability
In simple terms: PAPS is made in the cytosol before it can be transported.
PAPS is synthesized in the cytosol by the bifunctional enzyme PAPS synthetase, which comprises ATP sulfurylase and APS kinase domains. This enzyme converts ATP and sulfate into adenosine 5'-phosphosulfate (APS) and then phosphorylates APS to PAPS, consuming two ATP molecules per PAPS. The cytosolic concentration of PAPS is tightly regulated and serves as the substrate pool for transporters.
Recognition and Binding by PAPS Transporters
In simple terms: Transporter proteins recognize PAPS and bind it for translocation.
PAPS transporters, such as PAPST1 (SLC35B2) and PAPST2 (SLC35B3), are multi-pass transmembrane proteins localized primarily to the Golgi membrane. They bind PAPS with high affinity and specificity, distinguishing it from other nucleotides like ATP or APS. The binding site likely involves conserved basic residues that interact with the phosphate and sulfate groups of PAPS.
Translocation Across the Golgi Membrane
In simple terms: The transporter moves PAPS from the cytosol into the Golgi lumen.
Following binding, PAPS is translocated across the lipid bilayer into the Golgi lumen, where it serves as the sulfate donor for Golgi-resident sulfotransferases. This transport is thought to be driven by the concentration gradient of PAPS and possibly by antiport with other nucleotides, although the exact stoichiometry remains under investigation. The transport step is essential because sulfotransferases are lumenal enzymes and cannot access cytosolic PAPS.
Delivery to Sulfotransferases and Sulfation Reactions
In simple terms: Once inside the Golgi, PAPS is used to add sulfate groups to sugars and proteins.
Inside the Golgi lumen, PAPS is utilized by various sulfotransferases, including chondroitin sulfate synthases, heparan sulfate sulfotransferases, and protein tyrosine sulfotransferases. These enzymes transfer the sulfate group from PAPS to acceptor substrates, releasing 3'-phosphoadenosine 5'-phosphate (PAP) as a byproduct. PAP is then dephosphorylated to AMP by PAP phosphatase, and the nucleotide moieties are recycled.
Regulation of PAPS Transport Activity
In simple terms: Cells adjust how much PAPS is transported based on need.
PAPS transport activity is regulated at multiple levels, including transcriptional control of transporter genes, post-translational modifications, and feedback inhibition by PAP or other nucleotides. Expression of PAPST1 and PAPST2 varies across tissues and developmental stages, contributing to tissue-specific sulfation patterns. In colorectal carcinoma, altered expression of PAPS transporters correlates with changes in sulfation capacity, suggesting that transport is a regulatory node in cancer.
Key Genes Involved in GO:0046963 3'-phosphoadenosine 5'-phosphosulfate transport
The following genes encode proteins directly involved in PAPS transport or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC35B2 (PAPST1) | Golgi PAPS transporter; delivers PAPS for GAG and protein sulfation | Knockout causes severe sulfation defects; implicated in cancer |
| SLC35B3 (PAPST2) | Golgi PAPS transporter; redundant with PAPST1 in some tissues | Essential for embryonic stem cell differentiation |
| PAPSS1 | Bifunctional PAPS synthetase (ATP sulfurylase/APS kinase); synthesizes PAPS | Target for modulating PAPS supply |
| PAPSS2 | Isoform of PAPS synthetase; tissue-specific expression | Mutations cause skeletal dysplasia |
| CHST3 | Chondroitin 6-sulfotransferase; uses PAPS in Golgi | Marker of GAG sulfation capacity |
| CHST11 | Chondroitin 4-sulfotransferase; uses PAPS | Involved in cartilage development |
| UST | Uronyl 2-sulfotransferase; uses PAPS for heparan sulfate | Modulates growth factor signaling |
| HS6ST1 | Heparan sulfate 6-O-sulfotransferase; uses PAPS | Regulates Wnt and FGF signaling |
| TPST1 | Protein tyrosine sulfotransferase 1; uses PAPS | Modifies chemokine receptors |
| TPST2 | Protein tyrosine sulfotransferase 2; uses PAPS | Affects HIV entry and inflammation |
| SULT1A1 | Cytosolic sulfotransferase; uses PAPS for xenobiotic metabolism | Polymorphisms affect drug metabolism |
| SULT2A1 | Cytosolic sulfotransferase; sulfates steroids and bile acids | Regulated by nuclear receptors |
| PAPSS1 (isoform 1) | Brain-specific PAPS synthetase; kinetic properties characterized | Relevant to neuronal sulfation |
| SLC35B2 (variant) | Mutations may alter transport kinetics | Candidate for sulfation disorders |
| SLC35B3 (variant) | Alternatively spliced forms | Tissue-specific roles |
| B3GAT3 | Glucuronyltransferase; not a transporter but modifies GAGs | Indirectly affects PAPS utilization |
| EXT1 | Heparan sulfate polymerase; requires PAPS | Mutations cause hereditary multiple exostoses |
| EXT2 | Heparan sulfate polymerase; requires PAPS | Tumor suppressor in exostoses |
How Is 3'-phosphoadenosine 5'-phosphosulfate transport Regulated?
PAPS transport is regulated at the transcriptional level by tissue-specific transcription factors and at the post-translational level by modifications that affect transporter localization or activity. Expression of SLC35B2 and SLC35B3 is developmentally regulated and varies among tissues, contributing to distinct sulfation patterns. In cancer, altered expression of these transporters may reflect changes in differentiation state or oncogenic signaling. Additionally, feedback inhibition by PAP or other nucleotides may modulate transport efficiency.
3'-phosphoadenosine 5'-phosphosulfate transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC35B2 | Colorectal carcinoma | Knockout in HCT116 cells; xenograft |
| SLC35B3 | Embryonic stem cell differentiation | Knockout in mouse ES cells |
| PAPSS2 | Skeletal dysplasia | Point mutation knock-in in mice |
| CHST3 | Chondrodysplasia | Overexpression in chondrocytes |
| TPST1 | Inflammation and HIV entry | Knockout in Jurkat cells |
Colorectal Carcinoma
Expression of PAPS transporters is altered in human colorectal carcinoma, and changes correlate with tumor progression and sulfation capacity. Knockdown of PAPST1 in colorectal cancer cell lines reduces sulfation of glycans and affects cell proliferation, suggesting that PAPS transport contributes to tumor biology.
Embryonic Stem Cell Differentiation Defects
Mouse embryonic stem cells lacking PAPST1 and PAPST2 show impaired maintenance and differentiation, highlighting the importance of PAPS transport in developmental processes. These defects are associated with reduced sulfation of glycans and proteins essential for signaling.
Skeletal Dysplasias
Mutations in PAPS synthetase (PAPSS2) cause skeletal abnormalities due to impaired PAPS supply, and by extension, defects in PAPS transport could contribute to similar phenotypes. Chondroitin sulfate sulfation in cartilage depends on PAPS delivery to the Golgi.
From 3'-phosphoadenosine 5'-phosphosulfate transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC35B2 loss impair GAG sulfation? | Knockout in HEK293 or CHO cells |
| Does SLC35B3 compensate for SLC35B2 loss? | Double knockout in mouse ES cells |
| Does a point mutation in SLC35B2 alter PAPS binding? | Point mutation knock-in in HeLa cells |
| Can tagged SLC35B2 reveal Golgi localization dynamics? | Knock-in of GFP tag in HeLa cells |
| Does SLC35B2 overexpression increase sulfation? | Overexpression in colorectal cancer cells |
| Can CRISPR library screening identify modifiers of PAPS transport? | Genome-wide KO library in HCT116 |
How to Study the 3'-phosphoadenosine 5'-phosphosulfate transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive PAPS transport assay | Rate of PAPS uptake into vesicles | Quantifying transporter activity |
| Real-time RT-PCR | mRNA levels of SLC35B2/SLC35B3 | Tissue expression profiling |
| Immunohistochemistry | Protein localization and abundance | Tumor vs normal tissue |
| Metabolic [35S]sulfate labeling | GAG sulfation levels | Assessing sulfation capacity |
| CRISPR knockout screens | Genes affecting sulfation | Identifying modifiers |
| Fluorescent PAPS analogs | Transport kinetics in live cells | High-throughput screening |
| Western blotting | Transporter protein levels | Validating knockout/overexpression |
| Glycan mass spectrometry | Sulfation patterns of glycans | Structural analysis |
Transport Activity Assays
PAPS transport activity is measured using radioactive [35S]PAPS or fluorescent PAPS analogs in reconstituted Golgi vesicles or intact cells. These assays quantify the rate of PAPS uptake and can be adapted for high-throughput screening.
Expression Analysis by RT-PCR and Immunohistochemistry
Real-time reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry are used to quantify PAPS transporter mRNA and protein levels in tissues and cell lines. These methods reveal tissue-specific expression patterns and changes in disease states.
Glycosaminoglycan Sulfation Profiling
Sulfation of GAGs can be assessed by metabolic labeling with [35S]sulfate, followed by enzymatic digestion and chromatography. This approach links PAPS transport activity to specific GAG structures.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes that modulate PAPS transport or sulfation, as demonstrated in colorectal cancer cells. Such screens provide unbiased insights into the genetic network surrounding GO:0046963.
How CRISPR Can Be Used to Study GO:0046963 3'-phosphoadenosine 5'-phosphosulfate transport
Knockout
CRISPR knockout of SLC35B2 or SLC35B3 in cell lines such as HEK293 or HCT116 abolishes PAPS transport, leading to reduced GAG sulfation and altered cell behavior. These models are essential for studying the causal role of PAPS transport in development and cancer.
Point Mutation
Point mutations in the PAPS binding site of SLC35B2 can be introduced via CRISPR to dissect residues critical for substrate recognition and transport. Such models help distinguish transport defects from protein misfolding.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) into the endogenous SLC35B2 locus enables real-time imaging of transporter trafficking and localization in live cells. This approach preserves endogenous regulatory elements.
Overexpression
CRISPR activation or cDNA overexpression of SLC35B2/SLC35B3 increases PAPS transport capacity, which can enhance sulfation of glycans and proteins. Overexpression models are useful for studying gain-of-function effects in cancer.
How EDITGENE Supports 3'-phosphoadenosine 5'-phosphosulfate transport Research
Researchers studying 3'-phosphoadenosine 5'-phosphosulfate transport-related genes often need to determine whether a candidate gene is causally involved in sulfation-dependent processes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes in the PAPS transport pathway.
Contact EDITGENE today to design your custom CRISPR model for 3'-phosphoadenosine 5'-phosphosulfate transport research.
Frequently Asked Questions About 3'-phosphoadenosine 5'-phosphosulfate transport
What is 3'-phosphoadenosine 5'-phosphosulfate transport?
It is the biological process of moving PAPS, the universal sulfate donor, across cellular membranes via specific transporters, as defined by GO:0046963.
What genes are involved in 3'-phosphoadenosine 5'-phosphosulfate transport?
The main genes are SLC35B2 (PAPST1) and SLC35B3 (PAPST2), which encode Golgi-localized PAPS transporters.
Where does PAPS transport occur in the cell?
PAPS transport primarily occurs at the Golgi membrane, where transporters deliver cytosolic PAPS into the Golgi lumen for sulfation reactions.
Why is PAPS transport important for glycosaminoglycan synthesis?
GAG sulfation requires PAPS in the Golgi lumen, and without transporters, sulfotransferases cannot access PAPS, leading to undersulfated GAGs.
What diseases are associated with defects in PAPS transport?
Altered PAPS transport has been linked to colorectal carcinoma and embryonic stem cell differentiation defects, and may contribute to skeletal dysplasias.
How is PAPS transport activity measured?
It is measured using radioactive or fluorescent PAPS analogs in vesicle-based assays, as well as by RT-PCR and immunohistochemistry for transporter expression.
Can CRISPR be used to study PAPS transport?
Yes, CRISPR knockout, knock-in, and overexpression models of SLC35B2 and SLC35B3 are powerful tools to dissect PAPS transport function.
What is the role of PAPST1 and PAPST2?
PAPST1 and PAPST2 are Golgi PAPS transporters that deliver PAPS for sulfation; they are encoded by SLC35B2 and SLC35B3, respectively.
Is PAPS transport the same as PAPS synthesis?
No, PAPS synthesis occurs in the cytosol via PAPS synthetase, while PAPS transport moves the synthesized PAPS across membranes.
How does PAPS transport affect protein function?
PAPS transport enables tyrosine sulfation of proteins, which can modulate protein-protein interactions, such as chemokine receptor binding.
Conclusion
GO:0046963, 3'-phosphoadenosine 5'-phosphosulfate transport, is a fundamental biological process that bridges cytosolic PAPS synthesis and lumenal sulfation reactions. The identification of PAPST1 and PAPST2 as key transporters has illuminated how cells deliver the universal sulfate donor to the secretory pathway, with profound implications for glycosaminoglycan biosynthesis, protein modification, and embryonic development. Dysregulation of PAPS transport is increasingly recognized in cancer and developmental disorders, making it a compelling target for further research. Advances in CRISPR-based genome editing, combined with sensitive transport assays and multi-omics profiling, now allow researchers to dissect the causal roles of PAPS transporters in health and disease. EDITGENE's suite of knockout, knock-in, overexpression, and screening services empowers scientists to generate precisely engineered models and accelerate discoveries in sulfation biology.
References
- 1. Nishihara S et al.. 2021. Assay of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) transport activity.. PMID: 37590742
- 2. Egawa H et al.. 2022. Analysis of 3'-Phosphoadenosine 5'-Phosphosulfate Transporters: Transporter Activity Assay, Real-Time Reverse Transcription Polymerase Chain Reaction, and Immunohistochemistry.. Methods Mol Biol 2303:675-685 PMID: 34626415
- 3. Kamiyama S et al.. 2003. Molecular cloning and identification of 3'-phosphoadenosine 5'-phosphosulfate transporter.. J Biol Chem 278(28):25958-63 PMID: 12716889
- 4. Prydz K. 2015. Determinants of Glycosaminoglycan (GAG) Structure.. Biomolecules 5(3):2003-22 PMID: 26308067
- 5. Sasaki N et al.. 2009. The 3'-phosphoadenosine 5'-phosphosulfate transporters, PAPST1 and 2, contribute to the maintenance and differentiation of mouse embryonic stem cells.. PLoS One 4(12):e8262 PMID: 20011239
- 6. Wang LQ et al.. 2006. Inhibition of sulfotransferases by xenobiotics.. Curr Drug Metab 7(1):83-104 PMID: 16454694
- 7. Lansdon EB et al.. 2004. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase (isoform 1, brain): kinetic properties of the adenosine triphosphate sulfurylase and adenosine 5'-phosphosulfate kinase domains.. Biochemistry 43(14):4356-65 PMID: 15065880
- 8. Kamiyama S et al.. 2011. Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma.. Glycobiology 21(2):235-46 PMID: 20978009
